MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics 
Rhino Biotech has acquired cannabis genetics company and a biopharmaceutical company.
ANGUILLA, BRITISH OVERSEAS TERRITORIES / ACCESSWIRE / May 4, 2022 / Rhino Biotech Limited (OTC:RBRXF)294 Heywood House,South Hill1A AI-2640, AnguillaRhino...
IRLAB Announces Invitation to Presentation of the Interim Report for Q1 2022
GOTHENBURG, SWEDEN / ACCESSWIRE / May 4, 2022 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)IRLAB Therapeutics AB (publ) today announced that the...
Number of voting rights as of May 4, 2022
Nicox SASociété anonyme with a registered capital of € 43,223,135 Head Office:DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S....
Renowned Entrepreneur Vinod Ramchandra Jadhav Breaks Ground for the Renovation of Maharashtra Sahitya Parishad Library Cum Study Center
PUNE, INDIA / ACCESSWIRE / May 4, 2022 / Dubai-based entrepreneur Mr. Vinod Ramchandra Jadhav did the ground-breaking for the...
Valneva Initiates Heterologous Booster Trial of Inactivated, COVID-19 Vaccine Candidate
Saint-Herblain (France), May 4, 2022 – Valneva SE, a specialty vaccine company, today announced the initiation of a heterologous booster...
NLS Pharmaceutics Achieves 90% Enrollment Milestone in Quilience(R) Phase 2a Clinical Trial for Patients with Narcolepsy
Since the interim results were released in March, patient enrollment has nearly doubledOf the 60 patients planned for the study,...
Bavarian Nordic to Host First Quarter 2022 Results Conference Call and Webcast
COPENHAGEN, Denmark – May 4, 2022 - Bavarian Nordic A/S (OMX: BAVA) will announce its 2022 first quarter results on...
Xcelerate, Inc. Expands IP with Acquisition of Patent Portfolio
MAULDIN, SC / ACCESSWIRE / May 4, 2022 / Xcelerate, Inc. (OTC PINK:XCRT) today announced that it signed a purchase...
Top 12 Emerging Gene and Cell Therapy Technologies Likely to Impact Patient Care Announced in Annual “Disruptive Dozen” from Mass General Brigham
Breakthroughs range from restoration of sight and increasing the supply of donor organs, to treating brain cancer, hearing loss, and...
Evotec SE to Announce Results for the First Quarter 2022 on 11 May 2022
HAMBURG, GERMANY / ACCESSWIRE / May 4, 2022 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) will...
Umoja Biopharma Presents Data on its Synthetic Cytokine Receptor Platform at the International Society for Cell and Gene Therapy Annual Meeting 2022
RACR-induced cytotoxic innate lymphocytes permit the expansion and differentiation of iPSCs with fewer limitations, leading to a more cost-effective manufacturing...
Marker Therapeutics to Present Four Posters on its T Cell-Based Immunotherapies at the 2022 International Society for Cell & Gene Therapy Annual Meeting
HOUSTON, May 04, 2022 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the development of...
NATO Center of Excellence for Military Medicine to Study Brain Scientific’s NeuroCap Device
Brain Scientific partner LOK Corporation will illustrate the advantages of expanding EEG access with Brain Scientific’s neurology productsLAKEWOOD RANCH, Fla.,...
Annual General Meeting of Infant Bacterial Therapeutics
At the Annual General Meeting of Infant Bacterial Therapeutics AB (publ) on May 4, 2022, among other things, the following...
Cloud DX Signs Third Paramedical Service Provider with Peterborough County Paramedics
Paramedical Providers bring Remote Patient Monitoring (RPM) to Community CareNews in SummaryPeterborough County is the third Paramedical Provider to sign...
TOWER ONE ANNOUNCES FILING OF ITS Q4 AND YEAR 2021 ANNUAL REPORT
First year with positive EBITDA(1)Miami, FL, May 04, 2022 (GLOBE NEWSWIRE) -- TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF)...
Jupiter Wellness’ to Present JW-300 Topical Burn Treatment at SCALE 2022 Aesthetic Medicine, Plastic Surgery & Medical Dermatology Conference
JW-300 Demonstrated Efficacy in the Treatment of Developing Burns (sunburn) in a Double-Blinded Placebo-Controlled Clinical TrialJUPITER, FL / ACCESSWIRE /...
Rezolute, Inc. Announces Closing of Registered Direct Offering
REDWOOD CITY, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company dedicated to developing...
Pressure BioSciences Announces First Nanoemulsions Manufacturing Agreement Under Recently Released UST Early Access Program
Company Signs Development & Manufacturing Agreement with Safer Medical of Montana for Formulation, Pilot Batches, and Commercial Production of CBD...
Cyclacel Pharmaceuticals to Release First Quarter 2022 Financial Results
BERKELEY HEIGHTS, N.J., May 04, 2022 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"),...